Imidacloprid/Flumethrin

Verify with FDA CVM →

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Imidacloprid/Flumethrin

Administration Routes

Topical

Species Affected

Dog 8
Cat 4

Most Affected Breeds

Crossbred Canine/dog 2
Cat (unknown) 2
Dog (unknown) 2
Terrier - Cairn 1
Retriever - Golden 1
Himalayan 1
Terrier - Welsh 1
Domestic Mediumhair 1
Terrier - Bull - American Pit 1

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 5
Hyperactivity 2
Vomiting 2
Partial lack of efficacy 2
Anxiety 1
Pruritus 1
Decreased appetite 1
Systemic disorder NOS 1
Dermatitis 1
Self trauma 1
Foaming at the mouth 1
Itching 1

Outcome Breakdown

Recovered/Normal
6 (50.0%)
Outcome Unknown
6 (50.0%)

Data Summary

Metric Value
Total adverse event reports 12
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 9
Distinct reactions reported 16
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Imidacloprid/Flumethrin Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 12 adverse event reports referencing Imidacloprid/Flumethrin, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Imidacloprid/Flumethrin. Reported administration route is Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Imidacloprid/Flumethrin reports are Dog (8 reports), Cat (4 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (2), Cat (unknown) (2), Dog (unknown) (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Imidacloprid/Flumethrin are Lack of efficacy (ectoparasite) - flea (5), Hyperactivity (2), Vomiting (2), Partial lack of efficacy (2). Of the 12 reports with a coded outcome, Recovered/Normal is the leading category at 50.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Imidacloprid/Flumethrin.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial